These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 29147991)
41. Molecular characterization of the gut microbiome in egyptian patients with remitting relapsing multiple sclerosis. Mekky J; Wani R; Said SM; Ashry M; Ibrahim AE; Ahmed SM Mult Scler Relat Disord; 2022 Jan; 57():103354. PubMed ID: 35158462 [TBL] [Abstract][Full Text] [Related]
42. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle. Elsayed NS; Aston P; Bayanagari VR; Shukla SK Front Immunol; 2022; 13():972160. PubMed ID: 36045671 [TBL] [Abstract][Full Text] [Related]
43. Short-chain fatty acids and gut microbiota in multiple sclerosis. Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062 [TBL] [Abstract][Full Text] [Related]
44. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Cekanaviciute E; Yoo BB; Runia TF; Debelius JW; Singh S; Nelson CA; Kanner R; Bencosme Y; Lee YK; Hauser SL; Crabtree-Hartman E; Sand IK; Gacias M; Zhu Y; Casaccia P; Cree BAC; Knight R; Mazmanian SK; Baranzini SE Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10713-10718. PubMed ID: 28893978 [TBL] [Abstract][Full Text] [Related]
45. Alterations of host-gut microbiome interactions in multiple sclerosis. Cantoni C; Lin Q; Dorsett Y; Ghezzi L; Liu Z; Pan Y; Chen K; Han Y; Li Z; Xiao H; Gormley M; Liu Y; Bokoliya S; Panier H; Suther C; Evans E; Deng L; Locca A; Mikesell R; Obert K; Newland P; Wu Y; Salter A; Cross AH; Tarr PI; Lovett-Racke A; Piccio L; Zhou Y EBioMedicine; 2022 Feb; 76():103798. PubMed ID: 35094961 [TBL] [Abstract][Full Text] [Related]
46. Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract. Johanson DM; Goertz JE; Marin IA; Costello J; Overall CC; Gaultier A Sci Rep; 2020 Sep; 10(1):15183. PubMed ID: 32938979 [TBL] [Abstract][Full Text] [Related]
47. Interrelation of Diet, Gut Microbiome, and Autoantibody Production. Petta I; Fraussen J; Somers V; Kleinewietfeld M Front Immunol; 2018; 9():439. PubMed ID: 29559977 [TBL] [Abstract][Full Text] [Related]
48. New concepts on immunology of Multiple Sclerosis. Couloume L; Michel L Presse Med; 2021 Jun; 50(2):104072. PubMed ID: 34547375 [TBL] [Abstract][Full Text] [Related]
49. The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models. Gandy KAO; Zhang J; Nagarkatti P; Nagarkatti M Sci Rep; 2019 May; 9(1):6923. PubMed ID: 31061496 [TBL] [Abstract][Full Text] [Related]
50. Influence of a High-Impact Multidimensional Rehabilitation Program on the Gut Microbiota of Patients with Multiple Sclerosis. Barone M; Mendozzi L; D'Amico F; Saresella M; Rampelli S; Piancone F; La Rosa F; Marventano I; Clerici M; d'Arma A; Pugnetti L; Rossi V; Candela M; Brigidi P; Turroni S Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281224 [TBL] [Abstract][Full Text] [Related]
51. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis. Zeng Q; Junli Gong ; Liu X; Chen C; Sun X; Li H; Zhou Y; Cui C; Wang Y; Yang Y; Wu A; Shu Y; Hu X; Lu Z; Zheng SG; Qiu W; Lu Y Neurochem Int; 2019 Oct; 129():104468. PubMed ID: 31108132 [TBL] [Abstract][Full Text] [Related]
52. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications. Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698 [TBL] [Abstract][Full Text] [Related]
53. The second brain: The connection between gut microbiota composition and multiple sclerosis. Farshbafnadi M; Agah E; Rezaei N J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269 [TBL] [Abstract][Full Text] [Related]
54. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology? Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999 [No Abstract] [Full Text] [Related]
55. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. ; Cell; 2022 Sep; 185(19):3467-3486.e16. PubMed ID: 36113426 [TBL] [Abstract][Full Text] [Related]
57. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood. Yadav SK; Boppana S; Ito N; Mindur JE; Mathay MT; Patel A; Dhib-Jalbut S; Ito K Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9318-E9327. PubMed ID: 29078267 [TBL] [Abstract][Full Text] [Related]
58. Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity. Brown J; Robusto B; Morel L Front Immunol; 2020; 11():1741. PubMed ID: 32849620 [TBL] [Abstract][Full Text] [Related]
59. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342 [TBL] [Abstract][Full Text] [Related]
60. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis. Shahi SK; Ghimire S; Lehman P; Mangalam AK Front Immunol; 2022; 13():966417. PubMed ID: 36164343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]